eClinical Tech News

CrazyBulk, a sports nutrition brand, has launched a 2026 marketing push positioning its “legal, non-hormonal” SARM-style supplements as safer...

Immunocore laid out a 2026 agenda centered on expanding its melanoma franchise and advancing its TCR bispecific platform beyond...

ImmuCell posted preliminary 2025 results and a strategic reset. Fourth-quarter sales reached $7.6 million, down 1.6% year over year,...

CrazyBulk has launched a 2026 marketing and product push around “legal SARM-style” bulking stacks, pairing a detailed buyer’s guide...

CorMedix Therapeutics has consolidated its leadership bench as it scales into a multi-brand anti-infectives and hospital products company. The...

Coherus Oncology has introduced the non-proprietary name tagmokitug for its anti-CCR8 monoclonal antibody and published preclinical and translational clinical...

Soleno Therapeutics has published the pivotal randomized withdrawal data for VYKAT XR (diazoxide choline extended-release) in the Journal of...

Halozyme Therapeutics and Skye Bioscience have signed a non-exclusive global collaboration and license agreement enabling Skye to use Halozyme’s...

Medicus Pharma has consolidated financial and operational leadership by appointing President Carolyn Bonner as Chief Financial Officer, following the...

INVO Fertility has realigned its leadership to accelerate a clinic-focused growth strategy. Terah Krigsvold, previously the company’s controller, has...